Corrigendum to "Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway" [Canc. Lett. (2023) 216142]
Cancer Lett. 2023 Jul 28:567:216195.
doi: 10.1016/j.canlet.2023.216195.
Epub 2023 May 6.
1 National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Breast Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
2 School of Basic Medical Sciences, Ningxia Medical University, Ningxia, 750004, China; Key Laboratory of Fertility Maintenance Ministry of Education, Ningxia Medical University, Ningxia, 750004, China.
3 Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, 200241, China.
4 Breast Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
5 Breast Department, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. Electronic address: cqj55@163.com.
6 Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, 200241, China. Electronic address: yhchen@bio.ecnu.edu.cn.
7 National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. Electronic address: huangluqi01@126.com.